Molecular Epidemiology of Female Lung Cancer
AbstractLung cancer is still a leading cause of cancer mortality in the world. The incidence of lung cancer in developed countries started to decrease mainly due to global anti-smoking campaigns. However, the incidence of lung cancer in women has been increasing in recent decades for various reasons. Furthermore, since the screening of lung cancer is not as yet very effective, clinically applicable molecular markers for early diagnosis are much required. Lung cancer in women appears to have differences compared with that in men, in terms of histologic types and susceptibility to environmental risk factors. This suggests that female lung cancer can be derived by carcinogenic mechanisms different from those involved in male lung cancer. Among female lung cancer patients, many are non-smokers, which could be studied to identify alternative carcinogenic mechanisms independent from smoking-related ones. In this paper, we reviewed molecular susceptibility markers and genetic changes in lung cancer tissues observed in female lung cancer patients, which have been validated by various studies and will be helpful to understand the tumorigenesis of lung cancer. View Full-Text
Share & Cite This Article
Yim, S.-H.; Chung, Y.-J. Molecular Epidemiology of Female Lung Cancer. Cancers 2011, 3, 1861-1876.
Yim S-H, Chung Y-J. Molecular Epidemiology of Female Lung Cancer. Cancers. 2011; 3(2):1861-1876.Chicago/Turabian Style
Yim, Seon-Hee; Chung, Yeun-Jun. 2011. "Molecular Epidemiology of Female Lung Cancer." Cancers 3, no. 2: 1861-1876.